GRANULES INDIA STOCKS
Consolidation push to continue as key raw material gets scarce: 11 small cap cement stocks which fit the bill and may see some action
In less than a month, two cement majors clearly showed their intent. The intent is to grow through an inorganic route. One by complete acquisition, the other by taking a large stake in the company. Another common thing, both of them are focussed on the southern part of India, where the cement companies have a history of being under pressure. So why are they looking toward southern India? The answer lies in something else. It is one of the key raw materials that have become scarce and that is what is leading to a situation where big players clearly know that if they have to grow their capacities they have to pick on companies which have access to that critical raw material. This aggressive consolidation is likely to continue and it is the smaller players which are likely to be targeted.
Nifty charts projecting 25,200 by December, says ICICI Securities. Top 94 stock picks
ICICI Securities' technical analysis forecasts Nifty reaching 25,200 by December 2024, supported strongly at 22,200. Midcaps and smallcaps indices are in a structural uptrend, expected to gain over 16% by year-end.
F&O stocks to buy today: RIL, Escorts among top 10 trading ideas for 24 June 2024
Indian market to trade lower with Nifty at 23460 levels. Chandan Taparia from Motilal Oswal Financial Services Limited provides F&O Strategy and expert stock recommendations with targets and stop loss levels.
Stock Radar: Granules India hits record high in June 2024; should traders buy or book profits in this pharma stock?
Granules India Ltd broke out from a bullish Flag pattern, hitting a record high of Rs 485. Traders can buy on dips towards 460 for a target of Rs 510-530 in 2-3 months. Technical indicators like RSI and MACD are positive.
F&O Stock Strategy: How to trade Granules India and Biocon
Nifty50 and Sensex surged by nearly 1% on Thursday, following their strongest single-day increase in over three years. This uptick came as Narendra Modi secured the prospect of a third term in office, with two crucial allies pledging their support to establish a new government.
Stock Radar: Granules stock rallies 50% in 1 year! Takes support above Rising Wedge formation
The stock rose from Rs 276 as of May 26, 2023, to Rs 434 on May 26, 2024. The pharma stock hit a record high of Rs 480 on 26th February but the momentum fizzled. It witnessed a steady decline, which took the stock below 50-DMA on the daily charts. After remaining range-bound for the past few months, the stock took support above the broadening Rising Wedge formation in May and bounced back.
Bad news flow & good stock prices: 5 agro-chemical stocks with upside potential of up to 30%
What is the news flow regarding the agrochemical sector today? Probably the following: China is dumping, there is over capacity in many segments, over inventory issues are plaguing the industry globally, erratic weather conditions in different parts of the world. One would feel agro chemical stocks are better avoided now. But in markets, when the news flow is bad, stock prices are probably good. Also, in the case of the agro chemicals sector, it's mostly short term issues. So, it is time to keep them on the watch list.
Comeback and re-rating supported by numbers? 5 pharma stocks with upside potential of up to 21%
Both at the real business condition and on the valuation cycle on the street. The Indian pharmaceutical sector has undergone significant changes over the past decade. Marking a transition from a period of consolidation and valuation readjustment to one where the focus has shifted towards more sustainable and compliant operational practices. This transformation highlights a shift in the strategic approach adopted by pharmaceutical companies. Historically, the expansion strategies of many pharma companies were driven by optimistic powerpoint presentations forecasting market growth. However, this approach often overlooked the critical aspect of regulatory compliance, leading to various challenges. Over the years the Indian pharmaceutical industry has understood that regulatory compliance might be slightly more time consuming and also expensive but in long run it pays both for the real business growth and improving valuations. Will the industry remember the critical lesson is key.
Ahead of Market: 10 things that will decide D-Street action on Wednesday
Nifty on Tuesday ended 49 points lower to once again form a Doji candle on the daily chart. The index is now in the process of retesting the breakout of 22,300 it gave last week.
Technical Stock Pick: 20% rally in 3 months! This pharma stock breaks out from a rounding bottom pattern; time to buy?
Short-term traders can look to buy the stock now for a target of Rs 590 in the next 3 months, suggest experts.
F&O stocks: Polycab, MCX among 5 stocks with long buildup
Polycab price surged 3.18%, and open interest saw an increase of 0.46%. Grasim Industries stock rose 3.01%, and the open interest saw an increase of 0.45%.
Stock Radar: Up 50% in 6 months! Why Granules India could keep hitting record highs: Ajit Mishra
The pharma stock rose from Rs 291 on August 14 to Rs 435 recorded on February 15, which translates into an upside of about 50% in six months. It rose more than 6% in a week and over 20% in the last 3 months. The momentum helped the stock to break out from a month-long consolidation.
Depository services player and a pharma stock offer 6-7% gains
Nifty started strong and fought off all adversaries despite setbacks. It managed to close flat.
Buy Granules India, target price Rs 475: Motilal Oswal
Granules India Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.
Book some profit in GAIL, Bhel; a buy on Granules India: Aditya Arora
Aditya Arora says: “The high beta counters have been little overstretched and valuation is hitting the roof, Nifty Pharma index is looking pretty good and components of the same are looking pretty good. In 2024, pharma index can dominate the trend. So, my stock pick would be Granules, which could be bought at Rs 414; Rs 390 should be the stop loss and Rs 460 should be the target.”
Stocks in news: PB Fintech, ZEE, PVR Inox, KFin Tech, Mazagon Dock
Zee Entertainment has sent a letter to Sony Group Corporation requesting an extension of the cutoff to complete the merger.
F&O Ban: Hindustan Copper, Manappuram Finance under trade ban on Thursday
The F&O contracts of any stock enter the ban period when the open interest (OI) on it crosses 95% of the market-wide positions limits or MWPL. The ban on it is reversed only if the open interest falls below 80%. Traders who trade in indices do not encounter a situation of security ban.
F&O Ban: Balrampur Chini, Indiabulls Housing among 4 stocks under trade ban on Wednesday
The Future & Options contracts of any stock enter the ban period when the open interest (OI) on it crosses 95% of the market wide positions limits or MWPL.
F&O Ban: Granules India, BHEL among 7 stocks under trade ban on Tuesday
Traders who trade in index do not encounter a situation of security ban.
Load More
